BPC-157 injected into the knee, one Florida clinic
Knee pain of several different causes
What a named clinic reported doing, in a published write-up. These are descriptions of practice, not evidence that the practice worked, and none of them had a control group.
Not advice. This is a record of a schedule, not a dose for you.
The schedule, as reported
Each field below is what the source states, not a rounded version of it. Where the source does not publish a detail, the field says so instead of filling the gap.
- Amount
- 2 to 4 mg
- Frequency
- One or two doses in total
- Route
- Intra-articular injection into the knee, given by a clinician
- Duration
- A single course, with follow up by telephone 6 to 12 months later
What was measured
Nothing was measured prospectively. Patients were telephoned 6 to 12 months afterwards and asked, from memory, whether their knee pain had improved. There was no validated pain scale, no imaging, no baseline score and no control group.
What was reported
Reports, not findings. Nothing below was produced by a controlled comparison.
17 patients were treated at one clinic between 2019 and 2020 and 16 were reached by telephone afterwards.
Of the 12 who received BPC-157 alone, 11 reported significant improvement in knee pain.
Of the 4 who also received thymosin beta-4, 3 reported significant improvement.
These are patients' recollections of their own pain, months later, described to the clinic that treated them.
Where this comes from
Lee and Padgett, Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain, Alternative Therapies in Health and Medicine, 2021. A retrospective chart review from a single Florida clinic.
Published, and therefore checkable, which is more than most clinic protocols offer. It is still a description of what one clinic did rather than a test of whether it worked, and the authors present it as such.
What this protocol cannot tell you
Required on every entry in this registry, and never empty.
A retrospective telephone survey of 17 people from one clinic cannot show that anything worked. With no control group there is nothing to compare the reported improvement against, and no way to separate the peptide from the injection itself, from six to twelve months passing, or from a patient's wish to give their doctor a good answer. Recalled pain is not a measurement. The same clinical group produced the other uncontrolled BPC-157 human reports in the literature, so the small human record for this compound is not independent of itself.
The compounds in this protocol
Each profile carries the full evidence record, the legal status and what the trials did not show.
- BPC-157
A pentadecapeptide with a large animal literature on tendon, ligament, muscle and gut healing, and a small human record: two rectal-enema studies run in Croatia, three uncontrolled clinic reports, and a randomized Phase 2 injury trial now recruiting.